These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14252669)

  • 1. [RENAL HEMODYNAMICS, WATER AND ELECTROLYTE ELIMINATION AFTER 4-CHLORO-N-(2-FURYLETHYL)-5-SULFAMOYLANTHRANILIC ACID].
    HEIDLAND A; KLUETSCH K; SUZUKI F
    Arzneimittelforschung; 1964 Jun; 14():713-6. PubMed ID: 14252669
    [No Abstract]   [Full Text] [Related]  

  • 2. RENAL HEMODYNAMIC AND ELECTROLYTE EXCRETION EFFECTS OF THE URINARY DIURETIC FACTOR (UDF).
    LITTLE JM
    J Pharmacol Exp Ther; 1965 Jun; 148():363-6. PubMed ID: 14334271
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METABOLIC EFFECTS AND SITE OF ACTION OF ETHACRYNIC ACID.
    LEDINGHAM JG; BAYLISS RI
    Clin Pharmacol Ther; 1965; 6():474-85. PubMed ID: 14314971
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential effects of diuretic agents on electrolyte excretion in the dog. Role of renal hemodynamics.
    Puschett JB; Kuhrman MA
    Nephron; 1979; 23(1):38-45. PubMed ID: 450165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EFFECT OF FUROSEMIDE ON RENAL MEDULLARY SODIUM GRADIENT.
    HOOK JB; WILLIAMSON HE
    Proc Soc Exp Biol Med; 1965 Feb; 118():372-4. PubMed ID: 14268624
    [No Abstract]   [Full Text] [Related]  

  • 7. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure.
    Costello-Boerrigter LC; Smith WB; Boerrigter G; Ouyang J; Zimmer CA; Orlandi C; Burnett JC
    Am J Physiol Renal Physiol; 2006 Feb; 290(2):F273-8. PubMed ID: 16189291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans.
    Swärd K; Valsson F; Sellgren J; Ricksten SE
    Intensive Care Med; 2005 Jan; 31(1):79-85. PubMed ID: 15565364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [SITE AND MECHANISM OF ACTION OF FUROSEMIDE IN THE DISTAL NEPHRON IN HUMANS].
    BUCHBORN E; ANASTASAKIS S
    Klin Wochenschr; 1964 Nov; 42():1127-31. PubMed ID: 14348294
    [No Abstract]   [Full Text] [Related]  

  • 10. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACUTE INFUSION OF SYNTHETIC ANGIOTENSIN II IN PATIENTS WITH ESSENTIAL HYPERTENSION. ITS EFFECT ON RENAL HEMODYNAMICS AND ON ELECTROLYTE AND WATER EXCRETION.
    VAGNUCCI AI; LAULER DP; HICKLER RB; THORN GW
    Circulation; 1964 Apr; 29():SUPPL:523-32. PubMed ID: 14137487
    [No Abstract]   [Full Text] [Related]  

  • 12. [Features of the pharmacodynamics and pharmacokinetics of furosemide upon long-term administration in rats].
    Briukhanov VM; Zverev IaF; Lampatov VV; Zharikov AIu
    Eksp Klin Farmakol; 2007; 70(2):33-6. PubMed ID: 17523448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soy isoflavonoids exhibit in vitro biological activities of loop diuretics.
    Martínez RM; Giménez I; Lou JM; Mayoral JA; Alda JO
    Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1354S-1357S. PubMed ID: 9848498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.
    Schnackenberg CG; Merz E; Brooks DP
    Br J Pharmacol; 2003 Aug; 139(8):1383-8. PubMed ID: 12922924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A NEW SALIDIURETIC: 4-CHLORO-N-FURYLMETHL-5-SULFAMOYLANTHRANILIC ACID].
    GIULIANI A; URBINATI GC
    Clin Ter; 1964 Dec; 31():570-89. PubMed ID: 14266407
    [No Abstract]   [Full Text] [Related]  

  • 16. FRUSEMIDE AND BENDROFLUAZIDE IN HEALTHY SUBJECTS.
    FORRESTER TM; SHIRRIFFS GG
    Lancet; 1965 Feb; 1(7382):409-11. PubMed ID: 14238094
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute renal effects of high doses of furosemide administered intravenously in patients with advanced chronic renal insufficiency.
    Radò JP; Juhos E; Szende L; Marosi J; Takò J; Salamon F
    J Med; 1973; 4(4):219-32. PubMed ID: 4520349
    [No Abstract]   [Full Text] [Related]  

  • 18. Ultrastructural and physiological basis of nephron pharmacology.
    Stolarczyk J
    Mater Med Pol; 1971; 3(2):42-7. PubMed ID: 5005686
    [No Abstract]   [Full Text] [Related]  

  • 19. ADDITION OF THE SALURETIC ACTION OF FUROSEMIDE TO THE SALURETIC ACTION OF CERTAIN OTHER AGENTS.
    HOOK JB; WILLIAMSON HE
    J Pharmacol Exp Ther; 1965 Apr; 148():88-93. PubMed ID: 14279189
    [No Abstract]   [Full Text] [Related]  

  • 20. Indomethacin decreases furosemide-induced natriuresis and diuresis on the neonatal kidney.
    Reyes JL; Aldana I; Barbier O; Parrales AA; Melendez E
    Pediatr Nephrol; 2006 Nov; 21(11):1690-7. PubMed ID: 16932901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.